logo

For the Inventor, By the Inventor

Coatesville, PA, United States of America

Derek D Dunn

This inventor holds 19 USPTO granted patents and 3 published patent applications and 6 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Cephalon, Inc., Cephalon France, Smithkline Beecham Corporation. Active years: 2000-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Derek D Dunn. Retrieved from https://idiyas.com/inventor/derek-d-dunn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 

% Patents Active = 42.1

 

Average Co-Inventor Count = 7.2

ph-index = 6

Forward Citations = 88(Granted Patents)


Location History:

  • Thorndale, PA (US) (2000 - 2006)
  • Coatesville, PA (US) (2002 - 2014)

Company Filing History:

goldMedal19 out of 248 
 
Cephalon, Inc.
 patents
silverMedal1 out of 20 
 
Cephalon France
 patents
bronzeMedal1 out of 2,198 
 
Smithkline Beecham Corporation
 patents
4. 1 out of 8 
 
Teva Sante
 patents
where one patent can have more than one assignee

Years Active: 2000-2014

Loading Chart...
Loading Chart...
Areas of Expertise:
Tricyclic Derivatives
Pharmaceutical Use
Multicyclic Compounds
H3 Receptor Ligands
ALK Inhibitors
Pyrrolotriazines
Pyridazinone Derivatives
Thio-substituted Biarylmethanesulfinyl
Biaryl-methanesulfinyl
Substituted Thioacetamides
Quinoline-containing
Cysteine Protease
19 patents (USPTO):Explore Patents
1. 8765779 - Tricyclic derivatives and their pharmaceutical use and compositions (2014-07-01),
2. 8716493 - Multicyclic compounds and the use thereof (2014-05-06),
3. 8673916 - [object Object] (2014-03-18),
4. 8648067 - [object Object] (2014-02-11),
5. 8586588 - Aryl pyridazinone derivatives and their use as H3 receptor ligands (2013-11-19),
6. 8471005 - Pyrrolotriazines as ALK and JAK2 inhibitors (2013-06-25),
7. 8247414 - Pyridizinone derivatives and the use thereof as H3 inhibitors (2012-08-21),
8. 8207168 - Pyridazinone derivatives (2012-06-26),
9. 8153667 - Tricyclic aromatic and bis-phenyl sulfinyl derivatives (2012-04-10),
10. 7981907 - Thio-substituted biarylmethanesulfinyl derivatives (2011-07-19),
11. 7449481 - Thio-substituted biaryl-methanesulfinyl derivatives (2008-11-11),
12. 7314875 - Tricyclic aromatic and bis-phenyl sulfinyl derivatives (2008-01-01),
13. 7268132 - Substituted thioacetamides (2007-09-11),
14. RE39575 - Substituted thioacetamides (2007-04-16),
15. 7122679 - Multicyclic compounds and the use thereof (2006-10-17),

Title: Derek D Dunn - Innovative Inventor from Coatesville

Introduction: Derek D Dunn is a talented inventor hailing from Coatesville, Pennsylvania. His passion for innovation has led to numerous groundbreaking inventions in various fields.

Latest Patents: Derek D Dunn holds several patents in the areas of technology, healthcare, and consumer products. His recent patents showcase his commitment to creating solutions that improve everyday life.

Career Highlights: Throughout his career, Derek D Dunn has been recognized for his ingenuity and creativity. His inventions have garnered attention for their practicality and impact on society. From cutting-edge tech devices to sustainable energy solutions, Derek D Dunn's work has left a lasting impression on the innovation landscape.

Collaborations: Derek D Dunn has collaborated with leading companies and research institutions to bring his inventions to life. His ability to work with diverse teams and experts has resulted in successful partnerships that have pushed the boundaries of innovation.

Conclusion: Derek D Dunn's dedication to innovation and his relentless pursuit of new ideas make him a standout inventor in the Coatesville area. His contributions to the world of inventions continue to inspire and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…